KRTAP3-1

gene
On this page

Also known as KAP3.1

Summary

KRTAP3-1 (keratin associated protein 3-1, HGNC:16778) is a protein-coding gene on chromosome 17q21.2, encoding Keratin-associated protein 3-1 (Q9BYR8). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….

This protein is a member of the keratin-associated protein (KAP) family. The KAP proteins form a matrix of keratin intermediate filaments which contribute to the structure of hair fibers. KAP family members appear to have unique, family-specific amino- and carboxyl-terminal regions and are subdivided into three multi-gene families according to amino acid composition: the high sulfur, the ultrahigh sulfur, and the high tyrosine/glycine KAPs. This protein is a member of the high sulfur KAP family and the gene is localized to a cluster of KAPs at 17q12-q21.

Source: NCBI Gene 83896 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 22 total
  • MANE Select transcript: NM_031958

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:16778
Approved symbolKRTAP3-1
Namekeratin associated protein 3-1
Location17q21.2
Locus typegene with protein product
StatusApproved
AliasesKAP3.1
Ensembl geneENSG00000212901
Ensembl biotypeprotein_coding
Entrez83896

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000391588, ENST00000581033

RefSeq mRNA: 1 — MANE Select: NM_031958 NM_031958

CCDS: CCDS32645

Canonical transcript exons

ENST00000391588 — 1 exons

ExonStartEnd
ENSE000015093674100852141009128

Expression profiles

Bgee: expression breadth broad, 82 present calls, max score 51.67.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4632 / max 184.9496, expressed in 58 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1658630.463258

Top tissues by expression

124 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
skin of abdomenUBERON:000141651.67gold quality
zone of skinUBERON:000001449.75gold quality
skin of legUBERON:000151148.70gold quality
right lungUBERON:000216744.45gold quality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
bone marrow cellCL:000209236.16gold quality
right lobe of liverUBERON:000111436.04silver quality
ganglionic eminenceUBERON:000402335.49gold quality
gastrocnemiusUBERON:000138835.24gold quality
muscle of legUBERON:000138334.79gold quality
vaginaUBERON:000099634.40gold quality
bloodUBERON:000017833.44gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
liverUBERON:000210733.34silver quality
heart left ventricleUBERON:000208432.21gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
tibial arteryUBERON:000761031.93gold quality
islet of LangerhansUBERON:000000631.92gold quality
popliteal arteryUBERON:000225031.92gold quality
bone marrowUBERON:000237131.74gold quality
muscle tissueUBERON:000238531.06gold quality
prostate glandUBERON:000236730.60gold quality
subcutaneous adipose tissueUBERON:000219030.50gold quality
pancreasUBERON:000126430.13gold quality
esophagus mucosaUBERON:000246930.11gold quality
right atrium auricular regionUBERON:000663130.03gold quality
heartUBERON:000094830.00gold quality
stromal cell of endometriumCL:000225529.87gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.02

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

28 targeting KRTAP3-1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-19A-3P99.9875.332762
HSA-MIR-19B-3P99.9875.442754
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-548AT-5P99.9670.832666
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-469899.8471.414303
HSA-MIR-4639-5P99.8167.371028
HSA-MIR-34B-5P99.7867.561175
HSA-MIR-449C-5P99.7867.631168
HSA-MIR-2682-5P99.7367.381055
HSA-MIR-561-3P99.6470.903647
HSA-MIR-372-5P99.4169.112299
HSA-MIR-4786-3P99.3668.351390
HSA-MIR-371A-5P99.0866.511914
HSA-MIR-224-3P98.9168.421815
HSA-MIR-522-3P98.9168.561817
HSA-MIR-487A-5P98.8569.37993
HSA-MIR-487B-5P98.8569.48987
HSA-MIR-4477A98.8369.752952
HSA-MIR-2467-3P98.6567.181969
HSA-MIR-126398.1369.18459
HSA-MIR-6806-5P96.3768.74587
HSA-MIR-5586-3P95.5167.00805
HSA-MIR-317494.6363.64577
HSA-MIR-476593.1166.17737

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusKrtap3-1ENSMUSG00000047564
rattus_norvegicusKrtap3-1ENSRNOG00000012544

Paralogs (3): KRTAP24-1 (ENSG00000188694), KRTAP3-3 (ENSG00000212899), KRTAP3-2 (ENSG00000212900)

Protein

Protein identifiers

Keratin-associated protein 3-1Q9BYR8 (reviewed: Q9BYR8)

Alternative names: High sulfur keratin-associated protein 3.1, Keratin-associated protein 3.1

All UniProt accessions (1): Q9BYR8

UniProt curated annotations — full annotation on UniProt →

Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.

Subunit / interactions. Interacts with hair keratins.

Similarity. Belongs to the KRTAP type 3 family.

RefSeq proteins (1): NP_114164* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007659Keratin_matxFamily

Pfam: PF04579

UniProt features (6 total): repeat 4, chain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9BYR8-F142.360.00

Function

Pathways and Gene Ontology

Reactome pathways

2 pathways

IDPathway
R-HSA-6805567Keratinization
R-HSA-1266738Developmental Biology

MSigDB gene sets: 55 (showing top): MARTINEZ_RB1_TARGETS_DN, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, WNT_UP.V1_DN, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, GREB1_TARGET_GENES, HHEX_TARGET_GENES, HMG20B_TARGET_GENES, LHX9_TARGET_GENES, NKX2_3_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (2): structural molecule activity (GO:0005198), protein binding (GO:0005515)

GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Developmental Biology1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
molecular_function1
binding1
cytoplasm1
cellular anatomical structure1
intermediate filament1
intermediate filament cytoskeleton1
polymeric cytoskeletal fiber1

Protein interactions and networks

STRING

418 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
KRTAP3-1KRTAP11-1Q8IUC1716
KRTAP3-1KRTAP13-1Q8IUC0685
KRTAP3-1KRTAP15-1Q3LI76666
KRTAP3-1KRTAP9-3Q9BYQ3587
KRTAP3-1KRTAP9-4Q9BYQ2576
KRTAP3-1KRTAP4-3Q9BYR4570
KRTAP3-1KRTAP13-3Q3SY46567
KRTAP3-1KRT35Q92764543
KRTAP3-1KRT27Q7Z3Y8535
KRTAP3-1KRT80Q6KB66530
KRTAP3-1KRT38O76015520
KRTAP3-1KRT84Q9NSB2520
KRTAP3-1KRTAP4-1Q9BYQ7519
KRTAP3-1KRTAP24-1Q3LI83505
KRTAP3-1KRT36O76013504

IntAct

270 interactions, top by confidence:

ABTypeScore
KRTAP3-1NOTCH2NLApsi-mi:“MI:0915”(physical association)0.560
CFPKRTAP3-1psi-mi:“MI:0915”(physical association)0.560
CDKN1AKRTAP3-1psi-mi:“MI:0915”(physical association)0.560
ADAM12KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
CERKKRTAP3-1psi-mi:“MI:0915”(physical association)0.560
KRTAP9-3KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
KRTAP3-1MRPL40psi-mi:“MI:0915”(physical association)0.560
TEKT3KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
KRTAP3-1DMRT3psi-mi:“MI:0915”(physical association)0.560
DOCK2KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
KRTAP3-1CIMIP1psi-mi:“MI:0915”(physical association)0.560
KRTAP3-1PLSCR4psi-mi:“MI:0915”(physical association)0.560
LRRC41KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
FAM222BKRTAP3-1psi-mi:“MI:0915”(physical association)0.560
SAMD7KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
GSTP1KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
POLR1CKRTAP3-1psi-mi:“MI:0915”(physical association)0.560
PVRKRTAP3-1psi-mi:“MI:0915”(physical association)0.560
VENTXKRTAP3-1psi-mi:“MI:0915”(physical association)0.560
KRTAP3-1GNEpsi-mi:“MI:0915”(physical association)0.560
OTX1KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
WDR25KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
KRTAP6-1KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
KRTAP10-8KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
LCE3DKRTAP3-1psi-mi:“MI:0915”(physical association)0.560
AGXTKRTAP3-1psi-mi:“MI:0915”(physical association)0.560
MAPKBP1KRTAP3-1psi-mi:“MI:0915”(physical association)0.560
CYSRT1KRTAP3-1psi-mi:“MI:0915”(physical association)0.560

BioGRID (84): NOTCH2NL (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid), KRTAP3-1 (Two-hybrid)

ESM2 similar proteins: A1A580, A2A591, A2A5X4, A2A5X5, A8MUX0, A8MX34, B2RUR4, O13152, O93499, O93500, P02444, P02445, P02446, P02447, P02449, P02450, P02451, P04458, P07521, P08335, P0DV60, P20307, P20308, P25692, P60329, Q24JX8, Q24JX9, Q3LI81, Q3LI83, Q4KL71, Q5T749, Q5T750, Q5TA77, Q6PEX3, Q6R648, Q6S343, Q7TQM5, Q8IUC1, Q92012, Q98U05

Diamond homologs: A2A591, P02444, P02445, P02446, P02447, Q24JX8, Q24JX9, Q6S343, Q9BYR6, Q9BYR7, Q9BYR8, Q9D638, Q9D7P0, A2A5X5, A8MUX0, Q8IUC1

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 81 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization1518.2×3e-13
Formation of the cornified envelope611.5×1e-03

GO biological processes:

GO termPartnersFoldFDR
keratinization723.4×1e-05

Disease & clinical

Clinical variants and AI predictions

ClinVar

22 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance19
Likely benign3
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

190 predictions. Top by Δscore:

VariantEffectΔscore
17:41008957:T:Cdonor_gain0.8500
17:41008686:AG:Adonor_gain0.7400
17:41008841:A:ACdonor_gain0.7200
17:41008842:C:CCdonor_gain0.7200
17:41008847:T:TAdonor_gain0.7100
17:41008837:T:TAdonor_gain0.6900
17:41008845:AGT:Adonor_gain0.6900
17:41008879:A:Tacceptor_gain0.6800
17:41008845:A:ACdonor_gain0.6600
17:41008928:G:GCdonor_gain0.6600
17:41009007:T:Cdonor_gain0.6600
17:41008907:G:Adonor_gain0.6500
17:41008989:C:CAdonor_gain0.6400
17:41008845:AGTC:Adonor_gain0.6100
17:41009000:G:Cdonor_gain0.6100
17:41008823:G:Cdonor_gain0.6000
17:41008822:A:ACdonor_gain0.5800
17:41008894:A:ACdonor_gain0.5800
17:41008988:TC:Tdonor_gain0.5800
17:41008989:CC:Cdonor_gain0.5800
17:41008895:G:Cdonor_gain0.5700
17:41008846:G:Cdonor_gain0.5500
17:41008803:T:Adonor_gain0.5400
17:41008805:A:ACdonor_gain0.5200
17:41008806:C:CCdonor_gain0.5200
17:41008905:T:Cacceptor_gain0.5200
17:41008805:ACAG:Adonor_gain0.5100
17:41008806:CAGC:Cdonor_gain0.5100
17:41008818:A:Cdonor_gain0.5100
17:41008687:G:Cdonor_gain0.5000

AlphaMissense

635 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:41008879:A:GW66R0.884
17:41008879:A:TW66R0.884
17:41008877:C:AW66C0.876
17:41008877:C:GW66C0.876
17:41008973:G:CS34R0.830
17:41008973:G:TS34R0.830
17:41008975:T:GS34R0.830
17:41008836:A:GI80T0.817
17:41008836:A:CI80S0.765
17:41008875:A:GL67P0.747
17:41008872:A:TL68H0.722
17:41008967:G:CC36W0.717
17:41008969:A:GC36R0.705
17:41008824:G:AT84I0.703
17:41008878:C:AW66L0.693
17:41008879:A:CW66G0.669
17:41008880:G:CC65W0.664
17:41008934:G:CC47W0.661
17:41008884:G:AT64I0.657
17:41008982:G:CC31W0.651
17:41008961:A:CH38Q0.643
17:41008961:A:TH38Q0.643
17:41008872:A:GL68P0.637
17:41008947:A:TL43H0.636
17:41008974:C:AS34I0.625
17:41008882:A:GC65R0.617
17:41008977:G:TP33H0.617
17:41008878:C:GW66S0.610
17:41008931:A:CC48W0.607
17:41008875:A:TL67Q0.602

dbSNP variants (sampled 300 via entrez): RS1001168680 (17:41010385 C>G), RS1003639073 (17:41008553 T>C), RS1005981675 (17:41009523 A>G), RS1009681123 (17:41009391 T>C), RS1009774670 (17:41010321 T>G), RS1009985478 (17:41010410 C>T), RS1010425802 (17:41010864 C>T), RS1012227010 (17:41008620 G>T), RS1012556483 (17:41009816 A>C), RS1013886716 (17:41009858 A>G), RS1016086467 (17:41009541 T>C), RS1017077610 (17:41008022 G>A), RS1017151536 (17:41008332 A>G,T), RS1017414560 (17:41009423 C>A,T), RS1017550242 (17:41009125 C>G,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

21 total (human), top 21 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases methylation, increases expression5
Estradiolaffects expression, decreases expression3
Tetrachlorodibenzodioxinincreases expression2
Aflatoxin B1increases expression2
OTX015decreases expression1
mivebresibdecreases expression1
bisphenol Aaffects cotreatment, decreases methylation1
tris(2-butoxyethyl) phosphateaffects expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
sodium arsenitedecreases expression1
tebuconazoledecreases expression1
cylindrospermopsinincreases expression1
(+)-JQ1 compounddecreases expression1
Resveratrolaffects cotreatment, decreases expression1
Fulvestrantaffects cotreatment, decreases methylation1
Camptothecinincreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Silverincreases expression1
Urethanedecreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideincreases expression1
Copper Sulfateincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.